Europe seeks to expand big pharma monopoly at expense of poor people, warn NGOs ahead of TTIP talks
28 September 2014
We collect analytics data in order to understand site usage. This data is collected anonymously and is not associated to you personally. Decide what you want to share with us below.
The European Commission is putting the interests of multinational drug companies above those of millions of people with no access to affordable life-saving medicines, warn Oxfam and Health Action International.